ADs such as SLE are suspected to have a microbial aetiology that may amplify the risk of disease development in genetically susceptible individuals, particularly those with a first-degree relative previously diagnosed with SLE (Navarra et al
Benefits of BPC-157 Accelerated healing of tendons and ligaments Protection and repair of the gastrointestinal mucosa Anti-inflammatory effects in musculoskeletal injuries Potential support for muscle recovery and pain reduction Mechanism of Action BPC-157 appears to promote angiogenesis (new blood vessel formation) by upregulating growth factors such as VEGF
All preclinical data is consistently positive across musculoskeletal, GI, and neurological outcomes
Peptide Therapy at a Glance EXPECTED RESULTS Enhanced cellular repair, improved hormone balance, increased energy, better sleep, fat loss, and immune support TREATMENT LENGTH Varies daily or weekly administration over 412+ weeks depending on protocol RECOMMENDED SESSIONS Ongoing use for 13 months, with regular monitoring and dose adjustments WHERE IT TREATS Systemic works at the cellular level to support immune, endocrine, metabolic, and neurological systems WHAT IT TREATS Hormone imbalance, weight gain, poor recovery, fatigue, inflammation, aging, low libido, immune dysfunction, and neurological decline TREATMENT COST $350 $1,200/month (depending on the type of peptide and dosing protocol) What is Peptide Therapy
